Search research articles
Contact Us
Filters
Showing results (1-10 of 217) with videos related to
Page
of 22
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
October 19, 2011
Reduced-intensity allogeneic hematopoietic transplantation should be considered a standard of care for older patients with acute myeloid leukemia
Richard Champlin
Best Practice & Research. Clinical Haematology
|
December 7, 2013
Reduced intensity allogeneic hematopoietic transplantation is an established standard of care for treatment of older patients with acute myeloid leukemia
Richard Champlin
Blood
|
July 16, 2011
Now everyone has a donor for HSCT
Richard Champlin
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 4, 2011
Hematopoietic stem cell transplantation for treatment of myleodysplastic syndromes
Richard Champlin
Haematologica
|
February 2, 2020
Is unrelated donor or haploidentical hematopoietic transplantation preferred for patients with acute myeloid leukemia in remission?
Richard Champlin
Blood
|
July 12, 2014
Acute graft-versus-host disease: more than just alloreactivity
Richard Champlin
Drugs
|
December 14, 2002
Use of filgrastim for stem cell mobilisation and transplantation in high-dose cancer chemotherapy
Paolo Anderlini, Richard Champlin
Cancer Treatment and Research
|
March 23, 2002
Non-myeloablative allogeneic hematopoietic transplantation and induction of graft-versus-malignancy
Issa Khouri, Sergio Giralt, Richard Champlin
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
October 24, 2007
Fifth Annual International Umbilical Cord Blood Transplantation Symposium, Los Angeles, California, May 11-12, 2007
John Wagner, Richard Champlin, Lawrence D Petz
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
December 24, 2005
Symposium summary
John Wagner, Richard Champlin, Lawrence D Petz
Page
of 22
Search research articles
Search
Showing results (1-10 of 217) with videos related to
Sort By:
Page
of 22
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
October 19, 2011
Reduced-intensity allogeneic hematopoietic transplantation should be considered a standard of care for older patients with acute myeloid leukemia
Richard Champlin
Best Practice & Research. Clinical Haematology
|
December 7, 2013
Reduced intensity allogeneic hematopoietic transplantation is an established standard of care for treatment of older patients with acute myeloid leukemia
Richard Champlin
Blood
|
July 16, 2011
Now everyone has a donor for HSCT
Richard Champlin
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 4, 2011
Hematopoietic stem cell transplantation for treatment of myleodysplastic syndromes
Richard Champlin
Haematologica
|
February 2, 2020
Is unrelated donor or haploidentical hematopoietic transplantation preferred for patients with acute myeloid leukemia in remission?
Richard Champlin
Blood
|
July 12, 2014
Acute graft-versus-host disease: more than just alloreactivity
Richard Champlin
Drugs
|
December 14, 2002
Use of filgrastim for stem cell mobilisation and transplantation in high-dose cancer chemotherapy
Paolo Anderlini, Richard Champlin
Cancer Treatment and Research
|
March 23, 2002
Non-myeloablative allogeneic hematopoietic transplantation and induction of graft-versus-malignancy
Issa Khouri, Sergio Giralt, Richard Champlin
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
October 24, 2007
Fifth Annual International Umbilical Cord Blood Transplantation Symposium, Los Angeles, California, May 11-12, 2007
John Wagner, Richard Champlin, Lawrence D Petz
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
December 24, 2005
Symposium summary
John Wagner, Richard Champlin, Lawrence D Petz
Page
of 22